FDA Inspection 1291250 — Corcept Therapeutics Incorporated
The FDA completed an inspection of Corcept Therapeutics Incorporated on October 24, 2025 in Redwood City, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 24, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Redwood City, CA (United States)
Additional Details
Sponsor, Contract Research Organization